SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is under pressure as reports of a massive $250 billion AI infrastructure financing deal with OpenAI sparked market concerns over "circular financing" and credit risk. While some investors see this as a strategic move to solidify AI dominance, community discourse is divided between those viewing the pullback as a buying opportunity in a growth leader and others fearing an unsustainable AI bubble.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is facing intense downward pressure driven by market-wide fears over memory cycle peaks and concerns regarding competition from Chinese rivals. Community sentiment is deeply divided, with many long-term investors highlighting strong fundamentals and substantial order backlogs, while others are bracing for further volatility amid heavy institutional shorting and leveraged ETF activity.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending after a sharp decline following FDA briefing documents that criticized the company's statistical analysis plan and efficacy data for its Duchenne muscular dystrophy treatment, deramiocel. While the community is debating whether the FDA relied on obsolete trial protocols or if management mishandled the application, many investors are focused on the upcoming advisory committee meeting as a critical binary event that will determine the stock's future.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is facing extreme volatility as investors react to mixed semiconductor earnings and ongoing geopolitical tensions in the Middle East. The community remains deeply divided, with some traders attempting to capitalize on short-term price swings while others express concern over the potential for further downside as the sector navigates heavy institutional sell-offs and macro uncertainty.

Celestica, Inc. engages in the provision of supply chain solutions globally to equipment manufacturers and service providers. It operates through the Advanced Technology Solutions (ATS) and Connectivity and Cloud Solutions (CCS) segments. The ATS segment includes aerospace and defense, industrial, smart energy, health tech, and capital equipment businesses. The CCS segment consists of enterprise communications, telecommunications, servers, and storage businesses. The company was founded in 1994 and is headquartered in Toronto, Canada.

Celestica, Inc. - Ordinary Shares (Subordinate Voting)

Celestica, Inc.

Celestica is surging following a strong earnings beat and raised 2027 revenue guidance, which has fueled intense community debate over whether the AI infrastructure trade can sustain its momentum. Investors are closely monitoring hyperscaler capital expenditure as the primary catalyst, with many actively discussing whether current price levels represent a value opportunity or an overextended market cycle.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

The semiconductor sector is facing significant volatility as investors weigh strong long-term AI infrastructure demand against crowded positioning and valuation concerns. The iShares Semiconductor ETF is experiencing a sharp pullback that has triggered technical alerts and triggered intense community debate over whether this represents a healthy reset or the beginning of a deeper structural correction.

Direxion Shares ETF Trust - Direxion Daily TSLA Bull 2X ETF

Direxion Daily TSLA Bull 2X Shares

TSLL is currently experiencing intense retail trading activity driven by extreme volatility in the underlying Tesla stock. Investors are heavily focused on navigating rapid price swings, with community discussions centering on varying strategies like scalping, swing trading, and managing significant unrealized losses while speculating on potential future recovery catalysts.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is currently trending as investors weigh aggressive AI infrastructure spending against broader concerns about semiconductor valuation and potential market rotation. While community sentiment remains polarized between long-term bullish expectations for data center growth and fears of an AI-led market correction, active discussions focus heavily on upcoming earnings results and the sustainability of high capital expenditure from hyperscalers.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending as investors digest a massive revenue beat and the disclosure of $20 billion in new contracted lease value, signaling significant scaling in its AI data center infrastructure. The community is actively debating the company's ability to maintain this pace of execution against broader market volatility and concerns over stock-based compensation.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending due to the resolution of its arbitration with 3D Medicines, which investors are dissecting for its impact on the company's China licensing strategy and long-term cash position. The community remains heavily polarized, with bulls dismissing the ruling as minor 'noise' while focusing on the imminent Phase 3 REGAL trial catalyst, while bears argue the outcome signals deeper execution risks and potential share price volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$UDR Q2 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of $0.21 up 90.91% YoY
• Reported revenue of $425.4M
• UDR Inc has established third quarter 2026 guidance ranges for Net Income of $0.13 to $0.15, FFO of $0.63 to $0.65, and FFOA of $0.63 to $0.65 per diluted share.

Stocktwits

UDR Inc

 Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.21 up 90.91% YoY
• Reported revenue of $425.4M
• UDR Inc has established third quarter 2026 guidance ranges for Net Income of $0.13 to $0.15, FFO of $0.63 to $0.65, and FFOA of $0.63 to $0.65 per diluted share.

This account has been verified as an official STOCKTWITS representative.